Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
13,253
archived clinical trials in
Arthritis

Efficacy and Safety of the Lidoderm Patch Applied to Patients With Osteoarthritis of the Knee
Efficacy and Safety of the Lidocaine 5% Patch When Used as Adjunct Treatment in Patients With Osteoarthritis of the Knee Receiving Sub-Optimal Pain Relief From Their Current Analgesic Regimen
Status: Enrolling
Updated:  9/7/2017
Health Concepts
mi
from
Rapid City, SD
Efficacy and Safety of the Lidoderm Patch Applied to Patients With Osteoarthritis of the Knee
Efficacy and Safety of the Lidocaine 5% Patch When Used as Adjunct Treatment in Patients With Osteoarthritis of the Knee Receiving Sub-Optimal Pain Relief From Their Current Analgesic Regimen
Status: Enrolling
Updated: 9/7/2017
Health Concepts
mi
from
Rapid City, SD
Click here to add this to my saved trials
Efficacy and Safety of the Lidoderm Patch Applied to Patients With Osteoarthritis of the Knee
Efficacy and Safety of the Lidocaine 5% Patch When Used as Adjunct Treatment in Patients With Osteoarthritis of the Knee Receiving Sub-Optimal Pain Relief From Their Current Analgesic Regimen
Status: Enrolling
Updated:  9/7/2017
Radiant Research, Inc
mi
from
San Antonio, TX
Efficacy and Safety of the Lidoderm Patch Applied to Patients With Osteoarthritis of the Knee
Efficacy and Safety of the Lidocaine 5% Patch When Used as Adjunct Treatment in Patients With Osteoarthritis of the Knee Receiving Sub-Optimal Pain Relief From Their Current Analgesic Regimen
Status: Enrolling
Updated: 9/7/2017
Radiant Research, Inc
mi
from
San Antonio, TX
Click here to add this to my saved trials
Efficacy and Safety of the Lidoderm Patch Applied to Patients With Osteoarthritis of the Knee
Efficacy and Safety of the Lidocaine 5% Patch When Used as Adjunct Treatment in Patients With Osteoarthritis of the Knee Receiving Sub-Optimal Pain Relief From Their Current Analgesic Regimen
Status: Enrolling
Updated:  9/7/2017
Advanced Pain Management & Rehabilitation, Hilltop Medical
mi
from
Virginia Beach, VA
Efficacy and Safety of the Lidoderm Patch Applied to Patients With Osteoarthritis of the Knee
Efficacy and Safety of the Lidocaine 5% Patch When Used as Adjunct Treatment in Patients With Osteoarthritis of the Knee Receiving Sub-Optimal Pain Relief From Their Current Analgesic Regimen
Status: Enrolling
Updated: 9/7/2017
Advanced Pain Management & Rehabilitation, Hilltop Medical
mi
from
Virginia Beach, VA
Click here to add this to my saved trials
Diagnostic Genicular Nerve Block Prior to Radiofrequency Ablation for Knee Osteoarthritis Pain
A Prospective Trial of Zero Versus One Diagnostic Genicular Nerve Blocks to Determine Clinical Outcomes After Radiofrequency Ablation for the Treatment of Chronic Painful Knee Osteoarthritis
Status: Enrolling
Updated:  9/12/2017
Northwestern University
mi
from
Chicago, IL
Diagnostic Genicular Nerve Block Prior to Radiofrequency Ablation for Knee Osteoarthritis Pain
A Prospective Trial of Zero Versus One Diagnostic Genicular Nerve Blocks to Determine Clinical Outcomes After Radiofrequency Ablation for the Treatment of Chronic Painful Knee Osteoarthritis
Status: Enrolling
Updated: 9/12/2017
Northwestern University
mi
from
Chicago, IL
Click here to add this to my saved trials
Study of Apremilast to Evaluate the Safety and Effectiveness for Patients With Rheumatoid Arthritis
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study, To Compare the Efficacy and Safety of Two Doses of Apremilast (CC-10004) in Subjects With Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate
Status: Enrolling
Updated:  9/18/2017
ArthroCare, Arthritis Care Research
mi
from
Gilbert, AZ
Study of Apremilast to Evaluate the Safety and Effectiveness for Patients With Rheumatoid Arthritis
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study, To Compare the Efficacy and Safety of Two Doses of Apremilast (CC-10004) in Subjects With Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 9/18/2017
ArthroCare, Arthritis Care Research
mi
from
Gilbert, AZ
Click here to add this to my saved trials
Study of Apremilast to Evaluate the Safety and Effectiveness for Patients With Rheumatoid Arthritis
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study, To Compare the Efficacy and Safety of Two Doses of Apremilast (CC-10004) in Subjects With Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate
Status: Enrolling
Updated:  9/18/2017
Arizona Research Center
mi
from
Phoenix, AZ
Study of Apremilast to Evaluate the Safety and Effectiveness for Patients With Rheumatoid Arthritis
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study, To Compare the Efficacy and Safety of Two Doses of Apremilast (CC-10004) in Subjects With Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 9/18/2017
Arizona Research Center
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Study of Apremilast to Evaluate the Safety and Effectiveness for Patients With Rheumatoid Arthritis
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study, To Compare the Efficacy and Safety of Two Doses of Apremilast (CC-10004) in Subjects With Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate
Status: Enrolling
Updated:  9/18/2017
Desert Medical Advances
mi
from
Palm Desert, CA
Study of Apremilast to Evaluate the Safety and Effectiveness for Patients With Rheumatoid Arthritis
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study, To Compare the Efficacy and Safety of Two Doses of Apremilast (CC-10004) in Subjects With Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 9/18/2017
Desert Medical Advances
mi
from
Palm Desert, CA
Click here to add this to my saved trials
Study of Apremilast to Evaluate the Safety and Effectiveness for Patients With Rheumatoid Arthritis
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study, To Compare the Efficacy and Safety of Two Doses of Apremilast (CC-10004) in Subjects With Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate
Status: Enrolling
Updated:  9/18/2017
In Vivo Clinical Research
mi
from
Doral, FL
Study of Apremilast to Evaluate the Safety and Effectiveness for Patients With Rheumatoid Arthritis
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study, To Compare the Efficacy and Safety of Two Doses of Apremilast (CC-10004) in Subjects With Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 9/18/2017
In Vivo Clinical Research
mi
from
Doral, FL
Click here to add this to my saved trials
Study of Apremilast to Evaluate the Safety and Effectiveness for Patients With Rheumatoid Arthritis
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study, To Compare the Efficacy and Safety of Two Doses of Apremilast (CC-10004) in Subjects With Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate
Status: Enrolling
Updated:  9/18/2017
Jeffrey Alper, MD Research
mi
from
Naples, FL
Study of Apremilast to Evaluate the Safety and Effectiveness for Patients With Rheumatoid Arthritis
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study, To Compare the Efficacy and Safety of Two Doses of Apremilast (CC-10004) in Subjects With Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 9/18/2017
Jeffrey Alper, MD Research
mi
from
Naples, FL
Click here to add this to my saved trials
Study of Apremilast to Evaluate the Safety and Effectiveness for Patients With Rheumatoid Arthritis
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study, To Compare the Efficacy and Safety of Two Doses of Apremilast (CC-10004) in Subjects With Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate
Status: Enrolling
Updated:  9/18/2017
Tampa Medical Group, PA
mi
from
Tampa, FL
Study of Apremilast to Evaluate the Safety and Effectiveness for Patients With Rheumatoid Arthritis
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study, To Compare the Efficacy and Safety of Two Doses of Apremilast (CC-10004) in Subjects With Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 9/18/2017
Tampa Medical Group, PA
mi
from
Tampa, FL
Click here to add this to my saved trials
Study of Apremilast to Evaluate the Safety and Effectiveness for Patients With Rheumatoid Arthritis
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study, To Compare the Efficacy and Safety of Two Doses of Apremilast (CC-10004) in Subjects With Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate
Status: Enrolling
Updated:  9/18/2017
Alastair Kennedy, MD
mi
from
Vero Beach, FL
Study of Apremilast to Evaluate the Safety and Effectiveness for Patients With Rheumatoid Arthritis
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study, To Compare the Efficacy and Safety of Two Doses of Apremilast (CC-10004) in Subjects With Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 9/18/2017
Alastair Kennedy, MD
mi
from
Vero Beach, FL
Click here to add this to my saved trials
Study of Apremilast to Evaluate the Safety and Effectiveness for Patients With Rheumatoid Arthritis
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study, To Compare the Efficacy and Safety of Two Doses of Apremilast (CC-10004) in Subjects With Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate
Status: Enrolling
Updated:  9/18/2017
LaPorte County Institute for Clinical Research Inc.
mi
from
Michigan City, IN
Study of Apremilast to Evaluate the Safety and Effectiveness for Patients With Rheumatoid Arthritis
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study, To Compare the Efficacy and Safety of Two Doses of Apremilast (CC-10004) in Subjects With Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 9/18/2017
LaPorte County Institute for Clinical Research Inc.
mi
from
Michigan City, IN
Click here to add this to my saved trials
Study of Apremilast to Evaluate the Safety and Effectiveness for Patients With Rheumatoid Arthritis
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study, To Compare the Efficacy and Safety of Two Doses of Apremilast (CC-10004) in Subjects With Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate
Status: Enrolling
Updated:  9/18/2017
Associated Internal Medicine Specialists, PC
mi
from
Battle Creek, MI
Study of Apremilast to Evaluate the Safety and Effectiveness for Patients With Rheumatoid Arthritis
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study, To Compare the Efficacy and Safety of Two Doses of Apremilast (CC-10004) in Subjects With Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 9/18/2017
Associated Internal Medicine Specialists, PC
mi
from
Battle Creek, MI
Click here to add this to my saved trials
Study of Apremilast to Evaluate the Safety and Effectiveness for Patients With Rheumatoid Arthritis
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study, To Compare the Efficacy and Safety of Two Doses of Apremilast (CC-10004) in Subjects With Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate
Status: Enrolling
Updated:  9/18/2017
Saint Paul Rheumatology
mi
from
Eagan, MN
Study of Apremilast to Evaluate the Safety and Effectiveness for Patients With Rheumatoid Arthritis
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study, To Compare the Efficacy and Safety of Two Doses of Apremilast (CC-10004) in Subjects With Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 9/18/2017
Saint Paul Rheumatology
mi
from
Eagan, MN
Click here to add this to my saved trials
Study of Apremilast to Evaluate the Safety and Effectiveness for Patients With Rheumatoid Arthritis
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study, To Compare the Efficacy and Safety of Two Doses of Apremilast (CC-10004) in Subjects With Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate
Status: Enrolling
Updated:  9/18/2017
Physician's East
mi
from
Greenville, NC
Study of Apremilast to Evaluate the Safety and Effectiveness for Patients With Rheumatoid Arthritis
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study, To Compare the Efficacy and Safety of Two Doses of Apremilast (CC-10004) in Subjects With Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 9/18/2017
Physician's East
mi
from
Greenville, NC
Click here to add this to my saved trials
Study of Apremilast to Evaluate the Safety and Effectiveness for Patients With Rheumatoid Arthritis
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study, To Compare the Efficacy and Safety of Two Doses of Apremilast (CC-10004) in Subjects With Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate
Status: Enrolling
Updated:  9/18/2017
Health Research of Oklahoma
mi
from
Oklahoma City, OK
Study of Apremilast to Evaluate the Safety and Effectiveness for Patients With Rheumatoid Arthritis
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study, To Compare the Efficacy and Safety of Two Doses of Apremilast (CC-10004) in Subjects With Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 9/18/2017
Health Research of Oklahoma
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Study of Apremilast to Evaluate the Safety and Effectiveness for Patients With Rheumatoid Arthritis
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study, To Compare the Efficacy and Safety of Two Doses of Apremilast (CC-10004) in Subjects With Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate
Status: Enrolling
Updated:  9/18/2017
Modern Research Associates
mi
from
Dallas, TX
Study of Apremilast to Evaluate the Safety and Effectiveness for Patients With Rheumatoid Arthritis
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study, To Compare the Efficacy and Safety of Two Doses of Apremilast (CC-10004) in Subjects With Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 9/18/2017
Modern Research Associates
mi
from
Dallas, TX
Click here to add this to my saved trials
Study of Apremilast to Evaluate the Safety and Effectiveness for Patients With Rheumatoid Arthritis
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study, To Compare the Efficacy and Safety of Two Doses of Apremilast (CC-10004) in Subjects With Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate
Status: Enrolling
Updated:  9/18/2017
Stone Oak Rheumatology
mi
from
San Antonio, TX
Study of Apremilast to Evaluate the Safety and Effectiveness for Patients With Rheumatoid Arthritis
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study, To Compare the Efficacy and Safety of Two Doses of Apremilast (CC-10004) in Subjects With Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 9/18/2017
Stone Oak Rheumatology
mi
from
San Antonio, TX
Click here to add this to my saved trials
Study of Apremilast to Evaluate the Safety and Effectiveness for Patients With Rheumatoid Arthritis
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study, To Compare the Efficacy and Safety of Two Doses of Apremilast (CC-10004) in Subjects With Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate
Status: Enrolling
Updated:  9/18/2017
TriWest Research Associates
mi
from
La Mesa, CA
Study of Apremilast to Evaluate the Safety and Effectiveness for Patients With Rheumatoid Arthritis
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study, To Compare the Efficacy and Safety of Two Doses of Apremilast (CC-10004) in Subjects With Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 9/18/2017
TriWest Research Associates
mi
from
La Mesa, CA
Click here to add this to my saved trials
Study of Apremilast to Evaluate the Safety and Effectiveness for Patients With Rheumatoid Arthritis
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study, To Compare the Efficacy and Safety of Two Doses of Apremilast (CC-10004) in Subjects With Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate
Status: Enrolling
Updated:  9/18/2017
Stanford University Medical Center
mi
from
Palo Alto, CA
Study of Apremilast to Evaluate the Safety and Effectiveness for Patients With Rheumatoid Arthritis
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study, To Compare the Efficacy and Safety of Two Doses of Apremilast (CC-10004) in Subjects With Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 9/18/2017
Stanford University Medical Center
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Study of Apremilast to Evaluate the Safety and Effectiveness for Patients With Rheumatoid Arthritis
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study, To Compare the Efficacy and Safety of Two Doses of Apremilast (CC-10004) in Subjects With Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate
Status: Enrolling
Updated:  9/18/2017
Med Investigations/Sierra
mi
from
Roseville, CA
Study of Apremilast to Evaluate the Safety and Effectiveness for Patients With Rheumatoid Arthritis
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study, To Compare the Efficacy and Safety of Two Doses of Apremilast (CC-10004) in Subjects With Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 9/18/2017
Med Investigations/Sierra
mi
from
Roseville, CA
Click here to add this to my saved trials
Study of Apremilast to Evaluate the Safety and Effectiveness for Patients With Rheumatoid Arthritis
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study, To Compare the Efficacy and Safety of Two Doses of Apremilast (CC-10004) in Subjects With Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate
Status: Enrolling
Updated:  9/18/2017
Inland Rheumatology Clinical Trials, Inc.
mi
from
Upland, CA
Study of Apremilast to Evaluate the Safety and Effectiveness for Patients With Rheumatoid Arthritis
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study, To Compare the Efficacy and Safety of Two Doses of Apremilast (CC-10004) in Subjects With Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 9/18/2017
Inland Rheumatology Clinical Trials, Inc.
mi
from
Upland, CA
Click here to add this to my saved trials
Study of Apremilast to Evaluate the Safety and Effectiveness for Patients With Rheumatoid Arthritis
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study, To Compare the Efficacy and Safety of Two Doses of Apremilast (CC-10004) in Subjects With Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate
Status: Enrolling
Updated:  9/18/2017
Denver Arthritis Clinic
mi
from
Denver, CO
Study of Apremilast to Evaluate the Safety and Effectiveness for Patients With Rheumatoid Arthritis
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study, To Compare the Efficacy and Safety of Two Doses of Apremilast (CC-10004) in Subjects With Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 9/18/2017
Denver Arthritis Clinic
mi
from
Denver, CO
Click here to add this to my saved trials
Study of Apremilast to Evaluate the Safety and Effectiveness for Patients With Rheumatoid Arthritis
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study, To Compare the Efficacy and Safety of Two Doses of Apremilast (CC-10004) in Subjects With Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate
Status: Enrolling
Updated:  9/18/2017
San Marcus Research Clinic
mi
from
Miami, FL
Study of Apremilast to Evaluate the Safety and Effectiveness for Patients With Rheumatoid Arthritis
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study, To Compare the Efficacy and Safety of Two Doses of Apremilast (CC-10004) in Subjects With Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 9/18/2017
San Marcus Research Clinic
mi
from
Miami, FL
Click here to add this to my saved trials
Study of Apremilast to Evaluate the Safety and Effectiveness for Patients With Rheumatoid Arthritis
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study, To Compare the Efficacy and Safety of Two Doses of Apremilast (CC-10004) in Subjects With Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate
Status: Enrolling
Updated:  9/18/2017
Advanced Pharma CR, LLC
mi
from
Miami, FL
Study of Apremilast to Evaluate the Safety and Effectiveness for Patients With Rheumatoid Arthritis
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study, To Compare the Efficacy and Safety of Two Doses of Apremilast (CC-10004) in Subjects With Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 9/18/2017
Advanced Pharma CR, LLC
mi
from
Miami, FL
Click here to add this to my saved trials
Study of Apremilast to Evaluate the Safety and Effectiveness for Patients With Rheumatoid Arthritis
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study, To Compare the Efficacy and Safety of Two Doses of Apremilast (CC-10004) in Subjects With Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate
Status: Enrolling
Updated:  9/18/2017
Suncoast Clinical Research, Inc.
mi
from
New Port Richey, FL
Study of Apremilast to Evaluate the Safety and Effectiveness for Patients With Rheumatoid Arthritis
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study, To Compare the Efficacy and Safety of Two Doses of Apremilast (CC-10004) in Subjects With Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 9/18/2017
Suncoast Clinical Research, Inc.
mi
from
New Port Richey, FL
Click here to add this to my saved trials
Study of Apremilast to Evaluate the Safety and Effectiveness for Patients With Rheumatoid Arthritis
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study, To Compare the Efficacy and Safety of Two Doses of Apremilast (CC-10004) in Subjects With Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate
Status: Enrolling
Updated:  9/18/2017
David R. Mandel, Inc.
mi
from
Mayfield, OH
Study of Apremilast to Evaluate the Safety and Effectiveness for Patients With Rheumatoid Arthritis
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study, To Compare the Efficacy and Safety of Two Doses of Apremilast (CC-10004) in Subjects With Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 9/18/2017
David R. Mandel, Inc.
mi
from
Mayfield, OH
Click here to add this to my saved trials
Study of Apremilast to Evaluate the Safety and Effectiveness for Patients With Rheumatoid Arthritis
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study, To Compare the Efficacy and Safety of Two Doses of Apremilast (CC-10004) in Subjects With Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate
Status: Enrolling
Updated:  9/18/2017
Altoona Center for Clinical Research
mi
from
Duncansville, PA
Study of Apremilast to Evaluate the Safety and Effectiveness for Patients With Rheumatoid Arthritis
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study, To Compare the Efficacy and Safety of Two Doses of Apremilast (CC-10004) in Subjects With Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 9/18/2017
Altoona Center for Clinical Research
mi
from
Duncansville, PA
Click here to add this to my saved trials
Study of Apremilast to Evaluate the Safety and Effectiveness for Patients With Rheumatoid Arthritis
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study, To Compare the Efficacy and Safety of Two Doses of Apremilast (CC-10004) in Subjects With Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate
Status: Enrolling
Updated:  9/18/2017
Austin Regional Clinic
mi
from
Austin, TX
Study of Apremilast to Evaluate the Safety and Effectiveness for Patients With Rheumatoid Arthritis
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study, To Compare the Efficacy and Safety of Two Doses of Apremilast (CC-10004) in Subjects With Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 9/18/2017
Austin Regional Clinic
mi
from
Austin, TX
Click here to add this to my saved trials
Study of Apremilast to Evaluate the Safety and Effectiveness for Patients With Rheumatoid Arthritis
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study, To Compare the Efficacy and Safety of Two Doses of Apremilast (CC-10004) in Subjects With Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate
Status: Enrolling
Updated:  9/18/2017
Metroplex Research Center
mi
from
Dallas, TX
Study of Apremilast to Evaluate the Safety and Effectiveness for Patients With Rheumatoid Arthritis
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study, To Compare the Efficacy and Safety of Two Doses of Apremilast (CC-10004) in Subjects With Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 9/18/2017
Metroplex Research Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Study of Apremilast to Evaluate the Safety and Effectiveness for Patients With Rheumatoid Arthritis
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study, To Compare the Efficacy and Safety of Two Doses of Apremilast (CC-10004) in Subjects With Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate
Status: Enrolling
Updated:  9/18/2017
Sun Research Institute
mi
from
San Antonio, TX
Study of Apremilast to Evaluate the Safety and Effectiveness for Patients With Rheumatoid Arthritis
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study, To Compare the Efficacy and Safety of Two Doses of Apremilast (CC-10004) in Subjects With Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 9/18/2017
Sun Research Institute
mi
from
San Antonio, TX
Click here to add this to my saved trials
Study of Apremilast to Evaluate the Safety and Effectiveness for Patients With Rheumatoid Arthritis
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study, To Compare the Efficacy and Safety of Two Doses of Apremilast (CC-10004) in Subjects With Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate
Status: Enrolling
Updated:  9/18/2017
The Center for Excellence in Aging and Geriatric Health
mi
from
Williamsburg, VA
Study of Apremilast to Evaluate the Safety and Effectiveness for Patients With Rheumatoid Arthritis
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study, To Compare the Efficacy and Safety of Two Doses of Apremilast (CC-10004) in Subjects With Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 9/18/2017
The Center for Excellence in Aging and Geriatric Health
mi
from
Williamsburg, VA
Click here to add this to my saved trials
Study of Apremilast to Evaluate the Safety and Effectiveness for Patients With Rheumatoid Arthritis
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study, To Compare the Efficacy and Safety of Two Doses of Apremilast (CC-10004) in Subjects With Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate
Status: Enrolling
Updated:  9/18/2017
Arthritis Northwest Rheumatology
mi
from
Spokane, WA
Study of Apremilast to Evaluate the Safety and Effectiveness for Patients With Rheumatoid Arthritis
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study, To Compare the Efficacy and Safety of Two Doses of Apremilast (CC-10004) in Subjects With Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 9/18/2017
Arthritis Northwest Rheumatology
mi
from
Spokane, WA
Click here to add this to my saved trials
Study of Apremilast to Evaluate the Safety and Effectiveness for Patients With Rheumatoid Arthritis
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study, To Compare the Efficacy and Safety of Two Doses of Apremilast (CC-10004) in Subjects With Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate
Status: Enrolling
Updated:  9/18/2017
Revmatologie s.r.o.
mi
from
Brno,
Study of Apremilast to Evaluate the Safety and Effectiveness for Patients With Rheumatoid Arthritis
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study, To Compare the Efficacy and Safety of Two Doses of Apremilast (CC-10004) in Subjects With Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 9/18/2017
Revmatologie s.r.o.
mi
from
Brno,
Click here to add this to my saved trials
Yoga for Rheumatoid Arthritis
Yoga for Persons With Rheumatoid Arthritis
Status: Enrolling
Updated:  9/22/2017
Johns Hopkins Arthritis Center, 5501 Hopkins-Bayview Circle, Ste 1B.14
mi
from
Baltimore, MD
Yoga for Rheumatoid Arthritis
Yoga for Persons With Rheumatoid Arthritis
Status: Enrolling
Updated: 9/22/2017
Johns Hopkins Arthritis Center, 5501 Hopkins-Bayview Circle, Ste 1B.14
mi
from
Baltimore, MD
Click here to add this to my saved trials
The Effect of Weight Loss and Exercise on Knee Osteoarthritis
The Impact of Weight Loss and Exercise on Knee Osteoarthritis
Status: Enrolling
Updated:  9/22/2017
Johns Hopkins Bayview Medical Center
mi
from
Baltimore, MD
The Effect of Weight Loss and Exercise on Knee Osteoarthritis
The Impact of Weight Loss and Exercise on Knee Osteoarthritis
Status: Enrolling
Updated: 9/22/2017
Johns Hopkins Bayview Medical Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
A Study Comparing Sirukumab (CNTO 136) Monotherapy With Adalimumab (HUMIRA®) Monotherapy in the Treatment of Active Rheumatoid Arthritis
A Multicenter, Randomized, Double-blind, Parallel Group Study of Sirukumab Monotherapy Compared With HUMIRA® Monotherapy Administered Subcutaneously, in Subjects With Active Rheumatoid Arthritis
Status: Enrolling
Updated:  9/25/2017
Clinical Research Facility
mi
from
Birmingham, AL
A Study Comparing Sirukumab (CNTO 136) Monotherapy With Adalimumab (HUMIRA®) Monotherapy in the Treatment of Active Rheumatoid Arthritis
A Multicenter, Randomized, Double-blind, Parallel Group Study of Sirukumab Monotherapy Compared With HUMIRA® Monotherapy Administered Subcutaneously, in Subjects With Active Rheumatoid Arthritis
Status: Enrolling
Updated: 9/25/2017
Clinical Research Facility
mi
from
Birmingham, AL
Click here to add this to my saved trials
A Study Comparing Sirukumab (CNTO 136) Monotherapy With Adalimumab (HUMIRA®) Monotherapy in the Treatment of Active Rheumatoid Arthritis
A Multicenter, Randomized, Double-blind, Parallel Group Study of Sirukumab Monotherapy Compared With HUMIRA® Monotherapy Administered Subcutaneously, in Subjects With Active Rheumatoid Arthritis
Status: Enrolling
Updated:  9/25/2017
Clinical Research Facility
mi
from
Phoenix, AZ
A Study Comparing Sirukumab (CNTO 136) Monotherapy With Adalimumab (HUMIRA®) Monotherapy in the Treatment of Active Rheumatoid Arthritis
A Multicenter, Randomized, Double-blind, Parallel Group Study of Sirukumab Monotherapy Compared With HUMIRA® Monotherapy Administered Subcutaneously, in Subjects With Active Rheumatoid Arthritis
Status: Enrolling
Updated: 9/25/2017
Clinical Research Facility
mi
from
Phoenix, AZ
Click here to add this to my saved trials
A Study Comparing Sirukumab (CNTO 136) Monotherapy With Adalimumab (HUMIRA®) Monotherapy in the Treatment of Active Rheumatoid Arthritis
A Multicenter, Randomized, Double-blind, Parallel Group Study of Sirukumab Monotherapy Compared With HUMIRA® Monotherapy Administered Subcutaneously, in Subjects With Active Rheumatoid Arthritis
Status: Enrolling
Updated:  9/25/2017
Clinical Research Facility
mi
from
Arvin, CA
A Study Comparing Sirukumab (CNTO 136) Monotherapy With Adalimumab (HUMIRA®) Monotherapy in the Treatment of Active Rheumatoid Arthritis
A Multicenter, Randomized, Double-blind, Parallel Group Study of Sirukumab Monotherapy Compared With HUMIRA® Monotherapy Administered Subcutaneously, in Subjects With Active Rheumatoid Arthritis
Status: Enrolling
Updated: 9/25/2017
Clinical Research Facility
mi
from
Arvin, CA
Click here to add this to my saved trials
A Study Comparing Sirukumab (CNTO 136) Monotherapy With Adalimumab (HUMIRA®) Monotherapy in the Treatment of Active Rheumatoid Arthritis
A Multicenter, Randomized, Double-blind, Parallel Group Study of Sirukumab Monotherapy Compared With HUMIRA® Monotherapy Administered Subcutaneously, in Subjects With Active Rheumatoid Arthritis
Status: Enrolling
Updated:  9/25/2017
Clinical Research Facility
mi
from
El Cajon, CA
A Study Comparing Sirukumab (CNTO 136) Monotherapy With Adalimumab (HUMIRA®) Monotherapy in the Treatment of Active Rheumatoid Arthritis
A Multicenter, Randomized, Double-blind, Parallel Group Study of Sirukumab Monotherapy Compared With HUMIRA® Monotherapy Administered Subcutaneously, in Subjects With Active Rheumatoid Arthritis
Status: Enrolling
Updated: 9/25/2017
Clinical Research Facility
mi
from
El Cajon, CA
Click here to add this to my saved trials
A Study Comparing Sirukumab (CNTO 136) Monotherapy With Adalimumab (HUMIRA®) Monotherapy in the Treatment of Active Rheumatoid Arthritis
A Multicenter, Randomized, Double-blind, Parallel Group Study of Sirukumab Monotherapy Compared With HUMIRA® Monotherapy Administered Subcutaneously, in Subjects With Active Rheumatoid Arthritis
Status: Enrolling
Updated:  9/25/2017
Clinical Research Facility
mi
from
Huntington Beach, CA
A Study Comparing Sirukumab (CNTO 136) Monotherapy With Adalimumab (HUMIRA®) Monotherapy in the Treatment of Active Rheumatoid Arthritis
A Multicenter, Randomized, Double-blind, Parallel Group Study of Sirukumab Monotherapy Compared With HUMIRA® Monotherapy Administered Subcutaneously, in Subjects With Active Rheumatoid Arthritis
Status: Enrolling
Updated: 9/25/2017
Clinical Research Facility
mi
from
Huntington Beach, CA
Click here to add this to my saved trials
A Study Comparing Sirukumab (CNTO 136) Monotherapy With Adalimumab (HUMIRA®) Monotherapy in the Treatment of Active Rheumatoid Arthritis
A Multicenter, Randomized, Double-blind, Parallel Group Study of Sirukumab Monotherapy Compared With HUMIRA® Monotherapy Administered Subcutaneously, in Subjects With Active Rheumatoid Arthritis
Status: Enrolling
Updated:  9/25/2017
Clinical Research Facility
mi
from
Pleasanton, CA
A Study Comparing Sirukumab (CNTO 136) Monotherapy With Adalimumab (HUMIRA®) Monotherapy in the Treatment of Active Rheumatoid Arthritis
A Multicenter, Randomized, Double-blind, Parallel Group Study of Sirukumab Monotherapy Compared With HUMIRA® Monotherapy Administered Subcutaneously, in Subjects With Active Rheumatoid Arthritis
Status: Enrolling
Updated: 9/25/2017
Clinical Research Facility
mi
from
Pleasanton, CA
Click here to add this to my saved trials
A Study Comparing Sirukumab (CNTO 136) Monotherapy With Adalimumab (HUMIRA®) Monotherapy in the Treatment of Active Rheumatoid Arthritis
A Multicenter, Randomized, Double-blind, Parallel Group Study of Sirukumab Monotherapy Compared With HUMIRA® Monotherapy Administered Subcutaneously, in Subjects With Active Rheumatoid Arthritis
Status: Enrolling
Updated:  9/25/2017
Clinical Research Facility
mi
from
Thousand Oaks, CA
A Study Comparing Sirukumab (CNTO 136) Monotherapy With Adalimumab (HUMIRA®) Monotherapy in the Treatment of Active Rheumatoid Arthritis
A Multicenter, Randomized, Double-blind, Parallel Group Study of Sirukumab Monotherapy Compared With HUMIRA® Monotherapy Administered Subcutaneously, in Subjects With Active Rheumatoid Arthritis
Status: Enrolling
Updated: 9/25/2017
Clinical Research Facility
mi
from
Thousand Oaks, CA
Click here to add this to my saved trials
A Study Comparing Sirukumab (CNTO 136) Monotherapy With Adalimumab (HUMIRA®) Monotherapy in the Treatment of Active Rheumatoid Arthritis
A Multicenter, Randomized, Double-blind, Parallel Group Study of Sirukumab Monotherapy Compared With HUMIRA® Monotherapy Administered Subcutaneously, in Subjects With Active Rheumatoid Arthritis
Status: Enrolling
Updated:  9/25/2017
Clinical Research Facility
mi
from
Tustin, CA
A Study Comparing Sirukumab (CNTO 136) Monotherapy With Adalimumab (HUMIRA®) Monotherapy in the Treatment of Active Rheumatoid Arthritis
A Multicenter, Randomized, Double-blind, Parallel Group Study of Sirukumab Monotherapy Compared With HUMIRA® Monotherapy Administered Subcutaneously, in Subjects With Active Rheumatoid Arthritis
Status: Enrolling
Updated: 9/25/2017
Clinical Research Facility
mi
from
Tustin, CA
Click here to add this to my saved trials
A Study Comparing Sirukumab (CNTO 136) Monotherapy With Adalimumab (HUMIRA®) Monotherapy in the Treatment of Active Rheumatoid Arthritis
A Multicenter, Randomized, Double-blind, Parallel Group Study of Sirukumab Monotherapy Compared With HUMIRA® Monotherapy Administered Subcutaneously, in Subjects With Active Rheumatoid Arthritis
Status: Enrolling
Updated:  9/25/2017
Clinical Research Facility
mi
from
Whittier, CA
A Study Comparing Sirukumab (CNTO 136) Monotherapy With Adalimumab (HUMIRA®) Monotherapy in the Treatment of Active Rheumatoid Arthritis
A Multicenter, Randomized, Double-blind, Parallel Group Study of Sirukumab Monotherapy Compared With HUMIRA® Monotherapy Administered Subcutaneously, in Subjects With Active Rheumatoid Arthritis
Status: Enrolling
Updated: 9/25/2017
Clinical Research Facility
mi
from
Whittier, CA
Click here to add this to my saved trials
A Study Comparing Sirukumab (CNTO 136) Monotherapy With Adalimumab (HUMIRA®) Monotherapy in the Treatment of Active Rheumatoid Arthritis
A Multicenter, Randomized, Double-blind, Parallel Group Study of Sirukumab Monotherapy Compared With HUMIRA® Monotherapy Administered Subcutaneously, in Subjects With Active Rheumatoid Arthritis
Status: Enrolling
Updated:  9/25/2017
Clinical Research Facility
mi
from
Whittier, CA
A Study Comparing Sirukumab (CNTO 136) Monotherapy With Adalimumab (HUMIRA®) Monotherapy in the Treatment of Active Rheumatoid Arthritis
A Multicenter, Randomized, Double-blind, Parallel Group Study of Sirukumab Monotherapy Compared With HUMIRA® Monotherapy Administered Subcutaneously, in Subjects With Active Rheumatoid Arthritis
Status: Enrolling
Updated: 9/25/2017
Clinical Research Facility
mi
from
Whittier, CA
Click here to add this to my saved trials
A Study Comparing Sirukumab (CNTO 136) Monotherapy With Adalimumab (HUMIRA®) Monotherapy in the Treatment of Active Rheumatoid Arthritis
A Multicenter, Randomized, Double-blind, Parallel Group Study of Sirukumab Monotherapy Compared With HUMIRA® Monotherapy Administered Subcutaneously, in Subjects With Active Rheumatoid Arthritis
Status: Enrolling
Updated:  9/25/2017
Clinical Research Facility
mi
from
Newark, DE
A Study Comparing Sirukumab (CNTO 136) Monotherapy With Adalimumab (HUMIRA®) Monotherapy in the Treatment of Active Rheumatoid Arthritis
A Multicenter, Randomized, Double-blind, Parallel Group Study of Sirukumab Monotherapy Compared With HUMIRA® Monotherapy Administered Subcutaneously, in Subjects With Active Rheumatoid Arthritis
Status: Enrolling
Updated: 9/25/2017
Clinical Research Facility
mi
from
Newark, DE
Click here to add this to my saved trials
A Study Comparing Sirukumab (CNTO 136) Monotherapy With Adalimumab (HUMIRA®) Monotherapy in the Treatment of Active Rheumatoid Arthritis
A Multicenter, Randomized, Double-blind, Parallel Group Study of Sirukumab Monotherapy Compared With HUMIRA® Monotherapy Administered Subcutaneously, in Subjects With Active Rheumatoid Arthritis
Status: Enrolling
Updated:  9/25/2017
Clinical Research Facility
mi
from
Aventura, FL
A Study Comparing Sirukumab (CNTO 136) Monotherapy With Adalimumab (HUMIRA®) Monotherapy in the Treatment of Active Rheumatoid Arthritis
A Multicenter, Randomized, Double-blind, Parallel Group Study of Sirukumab Monotherapy Compared With HUMIRA® Monotherapy Administered Subcutaneously, in Subjects With Active Rheumatoid Arthritis
Status: Enrolling
Updated: 9/25/2017
Clinical Research Facility
mi
from
Aventura, FL
Click here to add this to my saved trials
A Study Comparing Sirukumab (CNTO 136) Monotherapy With Adalimumab (HUMIRA®) Monotherapy in the Treatment of Active Rheumatoid Arthritis
A Multicenter, Randomized, Double-blind, Parallel Group Study of Sirukumab Monotherapy Compared With HUMIRA® Monotherapy Administered Subcutaneously, in Subjects With Active Rheumatoid Arthritis
Status: Enrolling
Updated:  9/25/2017
Clinical Research Facility
mi
from
Dunedin, FL
A Study Comparing Sirukumab (CNTO 136) Monotherapy With Adalimumab (HUMIRA®) Monotherapy in the Treatment of Active Rheumatoid Arthritis
A Multicenter, Randomized, Double-blind, Parallel Group Study of Sirukumab Monotherapy Compared With HUMIRA® Monotherapy Administered Subcutaneously, in Subjects With Active Rheumatoid Arthritis
Status: Enrolling
Updated: 9/25/2017
Clinical Research Facility
mi
from
Dunedin, FL
Click here to add this to my saved trials
A Study Comparing Sirukumab (CNTO 136) Monotherapy With Adalimumab (HUMIRA®) Monotherapy in the Treatment of Active Rheumatoid Arthritis
A Multicenter, Randomized, Double-blind, Parallel Group Study of Sirukumab Monotherapy Compared With HUMIRA® Monotherapy Administered Subcutaneously, in Subjects With Active Rheumatoid Arthritis
Status: Enrolling
Updated:  9/25/2017
Clinical Research Facility
mi
from
Miami, FL
A Study Comparing Sirukumab (CNTO 136) Monotherapy With Adalimumab (HUMIRA®) Monotherapy in the Treatment of Active Rheumatoid Arthritis
A Multicenter, Randomized, Double-blind, Parallel Group Study of Sirukumab Monotherapy Compared With HUMIRA® Monotherapy Administered Subcutaneously, in Subjects With Active Rheumatoid Arthritis
Status: Enrolling
Updated: 9/25/2017
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials